DrugPatentWatch Database Preview
Actavis Llc Company Profile
What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?
ACTAVIS LLC has ten approved drugs.
There is one tentative approval on ACTAVIS LLC drugs.
Summary for Actavis Llc
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 10 |
| Patent Litigation for Actavis Llc: | See patent lawsuits for Actavis Llc |
| PTAB Cases with Actavis Llc as petitioner: | See PTAB cases with Actavis Llc as petitioner |
Drugs and US Patents for Actavis Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Llc | DAPSONE | dapsone | TABLET;ORAL | 204380-002 | Mar 23, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Llc | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | POWDER;INTRAVENOUS | 208723-001 | Sep 29, 2016 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Actavis Llc | HYDROXOCOBALAMIN | hydroxocobalamin | INJECTABLE;INJECTION | 085998-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | Start Trial | Start Trial | |||||
| Actavis Llc | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 204880-002 | Mar 5, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Llc | BUSULFAN | busulfan | INJECTABLE;INJECTION | 205139-001 | Dec 8, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
